THC TENET HEALTHCARE CORP: institutional ownership and insider trading
752 funds reported holding $18.1B of TENET HEALTHCARE CORP in their latest 13F filings; in Q2 2026 funds net sold $133M, with 88 new positions and 104 funds selling out; over the last 12 months insiders bought $0 and sold $71.7M on the open market.
Famous investors holding THC
- Larry Robbins (Glenview Capital): $418M, 7.6% of the portfolio
- Ken Griffin (Citadel Advisors): $394M, 0.1% of the portfolio
- Izzy Englander (Millennium Management): $89.3M, 0.0% of the portfolio
- Ray Dalio (Bridgewater Associates): $7.93M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $7.74M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $5.69M, 0.0% of the portfolio
Largest institutional holders of THC
- VANGUARD GROUP INC — $1.76B
- BlackRock, Inc. (BLK) — $1.64B
- PRICE T ROWE ASSOCIATES INC /MD/ — $1.49B
- Boston Partners — $829M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $793M
- FMR LLC — $747M
- VANGUARD CAPITAL MANAGEMENT LLC — $729M
- PeakShares LLC — $515M
- STATE STREET CORP (STT, STT-PG) — $515M
- GLENVIEW CAPITAL MANAGEMENT, LLC — $418M
Recent THC insider trades
- Sep 14, 2026: Kerrey J Robert sold 12,010 shares ($3.17M)
- Sep 10, 2026: Mark Richard J sold 10,000 shares ($2.63M)
- Sep 2, 2026: West Nadja sold 1,152 shares ($298K)
- Aug 31, 2026: Foo Lisa Y sold 24,000 shares ($6.39M)
Members of Congress trading THC
- Apr 20, 2026: Jonathan L. Jackson sold $15.0K–$50.0K
- Apr 15, 2026: Jonathan L. Jackson sold $1.00K–$15.0K
- Feb 11, 2026: Jonathan L. Jackson sold part of $1.00K–$15.0K
- Dec 10, 2025: Jonathan L. Jackson bought $15.0K–$50.0K
- Sep 3, 2025: Jonathan L. Jackson bought $1.00K–$15.0K
- Aug 4, 2025: Lisa C. McClain sold $1.00K–$15.0K
- Jun 11, 2025: Lisa C. McClain bought $1.00K–$15.0K
- Sep 4, 2024: John James sold $1.00K–$15.0K
- Nov 10, 2023: John James bought $1.00K–$15.0K
5%+ owners
- BlackRock, Inc.: 10.0% (Schedule 13G/A, filed Sep 4, 2026)
- T. Rowe Price Associates, Inc.: 9.2% (Schedule 13G/A, filed Aug 14, 2026)
- Vanguard Capital Management: 5.3% (Schedule 13G, filed Apr 30, 2026)